Labshake search
Citations for R&D Systems :
601 - 650 of 3760 citations for Testosterone 100 Ug Ml In Methylene Chloride 3 4 13C2 99%; 17 18O 98% since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
bioRxiv - Biophysics 2020Quote: ... cells were changed to long term DMEM/F12 media50 in the presence or absence of 3 ng/ml TGF-β1 (R&D Systems, Abingdon, UK). Media was replenished three times per week ...
-
bioRxiv - Pathology 2022Quote: ... BMMs were plated into 96-well or 24-well plates (3 × 104 cells per milliliter) in complete α-MEM culture media supplemented with 50 ng/mL RANKL (R&D Systems, USA) and 25 ng/mL M-CSF (PeproTech ...
-
bioRxiv - Neuroscience 2023Quote: ... On days 27 to 40 organoids were fed on alternate days with media containing 20 ng/mL NT-3 (R&D Systems, 267-N3) and 10 ng/mL BDNF (R&D Systems 248-BD) ...
-
bioRxiv - Bioengineering 2023Quote: ... Stem cells underwent directed differentiation into definitive endoderm over a 3-day treatment using Activin A (100ng/mL, R&D Systems Cat#338-AC) added to RPMI base media ...
-
bioRxiv - Neuroscience 2021Quote: ... These rats were then administered 50 μl of NRG-1β (1% BSA in PBS) or 50 μl of vehicle (1% BSA in PBS) treatment (20 ug/kg; EGF-like domain, R&D Systems, Minneapolis, MN) via bolus injection into the ICA through the ECA immediately before MCAO ...
-
bioRxiv - Pathology 2020Quote: ... goat polyclonal anti YM1/Chitinase-3 like 3 (R&D systems, Cat. No. AF2446, 1:400 dilution). Antigen retrieval of HIER2 (EDTA ...
-
bioRxiv - Immunology 2023Quote: ... the pellets obtained after centrifugation of the BAL fluid were pooled and stained for 30 min at 4°C with unconjugated polyclonal goat anti-mouse Ym1/2 (AF2446, R&D Systems; 1:100 diluted in PBS). After washing ...
-
bioRxiv - Immunology 2022Quote: ... IL-6 cat # D6050, IL-1Ra cat # DRA00B, IFN-γ cat #DY285B, IL-10 cat #DY21YB, IL-17 cat# DY317, R&D Systems, USA), following the instructions of the manufacturer ...
-
bioRxiv - Neuroscience 2020Quote: ... immunosorbent 96-well plate was coated overnight at +4°C with 1 μg/ml of goat anti-mouse CDNF (R&D Systems, AF5187) in coating buffer (15mM sodium carbonate ...
-
bioRxiv - Microbiology 2021Quote: Sterile tissue culture plates were coated overnight at 4°C with 5 µg/mL recombinant CD62P protein (R&D Systems, #137-PS-050). The following day the wells were washed 3X with PBS before being blocked with 1% BSA in PBS at room temperature (RT ...
-
bioRxiv - Bioengineering 2019Quote: ... 2013] consisting of the osteogenic media supplemented with 100 ng/mL BMP-2 (recombinant human BMP-2, 355-BM-050, R&D Systems). Media was replaced every 3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... monolayers grown with the differentiation media for 7 days were stimulated with human IFNβ (100 or 300 IU/ml, R&D systems) or IFNλ2 (10 or 30 ng/ml ...
-
bioRxiv - Biochemistry 2020Quote: In vitro co-precipitation of TREM2 or TREM1 with Aβ oligomers was performed by mixing recombinant Fc-tagged TREM2 or TREM1 ectodomain (residues 19-171; 100 ng/ml, R&D systems), 100 nM HiLyte Fluor 647-labelled Aβ oligomers and Protein G Dynabeads in 0.5% fatty acid free BSA PBS-Tween buffer ...
-
bioRxiv - Microbiology 2022Quote: ... Using density gradient medium (Lymphoprep) monocytes were isolated and differentiated into macrophages in the presence of GM-CSF (100 ng/mL) (R&D Systems) in 1640 RPMI + 5% FBS +P/S media for 6 to 7 days
-
bioRxiv - Immunology 2020Quote: ... 5 × 105 cells in 100 μl adhesion buffer were added to the upper chamber and either 500 ng/ml CCL2 (R&D Systems) or 10 nM C5a (R&D Systems ...
-
bioRxiv - Developmental Biology 2021Quote: ESCs were then differentiated into anteriormost primitive streak through the addition of CDM2 basal medium supplemented with Activin A (100 ng/mL; R&D Systems), CHIR99021 (3 µM ...
-
bioRxiv - Developmental Biology 2021Quote: ... and then differentiated into day 2 definitive endoderm through the addition of CDM2 basal medium supplemented with Activin A (100 ng/mL; R&D Systems), LDN-193189 (250 nM ...
-
bioRxiv - Developmental Biology 2021Quote: ... cells were exposed to 1 µM EdU along with or withpout 2-100 ng/ml recombinant VEGFA (R&D Systems, 493-MV) for 8 hours before being fixed and stained by the Click-iT EdU Alexa Fluor 488 Imaging Kit (Thermo Scientific ...
-
bioRxiv - Microbiology 2020Quote: ... the cells were incubated with either M1-activation medium [RPMI160 medium with 20 ng/ml IFNγ (485-MI-100; R&D systems) and 10 ng/ml LPS (L2630 ...
-
bioRxiv - Cell Biology 2021Quote: LECs were pre-cultured with FBS-free and supplement-free basal medium for 24 h and then treated with medium containing 100 ng/mL of recombinant rat CTGF (R&D Systems) for 5 min ...
-
bioRxiv - Immunology 2022Quote: ... Monocyte differentiation into macrophages was performed for 5-7 days in the presence of human M-CSF (100 ng/ml) (R&D system). On the day of the assay ...
-
bioRxiv - Bioengineering 2022Quote: The preosteoblast cells cultured in tissue culture plates were differentiated for 5 days and treated with Myostatin of 100 ng/mL (788-G8-010/CF R&D system), follistatin of 100 ng/mL (769-FS-025/CF ...
-
bioRxiv - Genetics 2023Quote: Reprogramming was done as described previously, combining the IFNγ (10 ng/ml, day 0 to 5) (R&D Systems, 485-MI-100) with the addition of the TET inhibitor molecule Bobcat 339 (concentration of 5 µM ...
-
bioRxiv - Cell Biology 2023Quote: ... The medium was changed daily for the next three days to DMEM/F12 supplemented with 100 ng/ml recombinant Activin-A (R&D Systems), 100 ng/ml fibroblast growth factor-2 (FGF2 ...
-
bioRxiv - Immunology 2024Quote: ... cells from BM (femora and tibiae) obtained from C57BL/6J mice were plated with 100 ng/ml or recombinant Flt3L (R&D systems) in RPMI1640 medium (Gibco ...
-
bioRxiv - Microbiology 2020Quote: ... Primary BMDCs were isolated from C57BL/6 mice and cultured in Dulbecco’s modified Eagle medium for 3–5 days in the presence of 20 ng/mL recombinant granulocyte-macrophage colony-stimulating factor (R&D Systems, Minneapolis, MN, USA) as described previously (83) ...
-
bioRxiv - Microbiology 2020Quote: ... were cultured in 24-well tissue dishes for 3 days in RPMI1640 medium supplemented with 100ng/ml Activin A (R&D Systems, 338-AC-050) and 2µM CHIR99021 (Tocris ...
-
bioRxiv - Bioengineering 2020Quote: ... cleaved caspase-3 (R&D System, MAB835) (1:150 in goat serum ...
-
bioRxiv - Genomics 2022Quote: ... 3 µM CHIR99021 (R&D Systems 4423), and 1 µM PD0325901 (Sigma PZ0162) ...
-
bioRxiv - Immunology 2021Quote: ... or recombinant ficolin-3 (R&D systems) or human purified C1q (Comp Tech ...
-
bioRxiv - Immunology 2020Quote: ... IFNλ2/3 ELISA (R&D Systems DY1789B) and mouse IFNβ ...
-
bioRxiv - Cell Biology 2021Quote: ... syndecan-3 (R&D Systems Cat#: FAB3539A) and syndecan-4 (R&D Systems Cat# ...
-
bioRxiv - Molecular Biology 2022Quote: ... 3 μM CHIR99021 (R&D Systems 4423), and 1 μM PD0325901 (Sigma PZ0162) ...
-
bioRxiv - Genomics 2023Quote: ... 3 μM CHIR99021 (R&D Systems 4423) was added to the media ...
-
bioRxiv - Immunology 2023Quote: ... anti-cleaved caspase-3 (R&D Systems), anti-RIPK3 (Abcam,) ...
-
bioRxiv - Genomics 2023Quote: ... 3 μM CHIR99021 (R&D Systems 4423), and 1 μM PD0325901 (Sigma PZ0162) ...
-
bioRxiv - Bioengineering 2022Quote: ... The cells were then cultured with bone morphogenic protein-4 (BMP-4; R&D Systems) and CHIR-99021 in RPMI-B27 medium to specify for cardiac mesoderm lineages ...
-
bioRxiv - Immunology 2022Quote: IL-4 complexes were generated by incubating 2 μg mouse rIL-4 (R&D Systems) with 10 μg LEAF purified anti-mouse IL4 antibody (clone 11B11 ...
-
bioRxiv - Immunology 2020Quote: ... and IL-10 were measured in the cell-free supernatants of control and treated MoDCs cultures (4×105 cells/ml) by ELISA assays (R&D Systems, Minneapolis, USA). The levels of cytokines produced by CD4+ T lymphocytes in co-cultures with MoDCs were evaluated in the cell-free supernatants of co-cultures ...
-
bioRxiv - Cell Biology 2022Quote: ... MC3T3-E1 Subclone 4 preosteoblasts (ATCC CRL-2593) grown in monolayer were treated with vehicle or CXCL12 (20 μg/ml, R&D Systems, 460-SD) for 4 hours ...
-
bioRxiv - Developmental Biology 2020Quote: ... Primary antibodies Nkx6.1 (1:100, DSHB) and Pdx1 (1:100, R&D Systems) were added and incubated for 30 minutes ...
-
bioRxiv - Immunology 2023Quote: ... KIR2DL1 (PE or APC, clone #143211, R&D systems, FAB1844P-100, FAB1844A-100), KIR2DS4 (PE-Cy7 ...
-
bioRxiv - Evolutionary Biology 2020Quote: ... to evacuate all mTeSR1 and then were treated for 24 hours with Activin A (100 ng/mL, R&D Systems, 338-AC-010), CHIR99021 (2 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... 100 µl of supernatant samples and standards (recombinant mouse TREM2-FC, 1729-T2; R&D Systems; 0-20 ng/ml in BSA-PBST) were then incubated for 2 hr at RT ...
-
bioRxiv - Cell Biology 2021Quote: ... Spain) and supplemented with each one of the following combinations of growth factors: (i) 100 ng/ml Act A (R&D Systems, UK), (ii ...
-
bioRxiv - Neuroscience 2020Quote: ... in culture medium with recombinant mouse TNF-α (10 ng/ml from a stock solution of 100 μg/ml made up in 0.2 % bovine serum albumin and sterile PBS, R&D systems, aa-80325) to stimulate release of inflammatory mediators (TNF-FLS ...
-
bioRxiv - Cancer Biology 2023Quote: ... HUES8 cells were treated with 3μM CHIR99021 (CHIR, Stem-RD, Hoover, AL) and 100 ng/mL Activin A (AA, R&D systems, Minneapolis, MN) in RPMI media (Cellgro ...
-
bioRxiv - Immunology 2022Quote: ... plated at 1-2×104 cells/well in 96 U-bottom plate and cultured for 3 – 6 days in cRPMI medium in the presence of IL-33 (R&D Systems, #3626, 50 ng/ml) or TSLP (R&D Systems ...
-
bioRxiv - Cell Biology 2022Quote: ... HSC cells were cultured in serum-free DMEM with 1% PSG and subjected to the different treatments: TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, USA; for 3 d), the ROCK inhibitor Y27632 (10 μM ...